Ran D. Balicer

16.9k total citations · 6 hit papers
261 papers, 8.8k citations indexed

About

Ran D. Balicer is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Ran D. Balicer has authored 261 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Epidemiology, 54 papers in Infectious Diseases and 47 papers in General Health Professions. Recurrent topics in Ran D. Balicer's work include SARS-CoV-2 and COVID-19 Research (23 papers), Vaccine Coverage and Hesitancy (21 papers) and Disaster Response and Management (17 papers). Ran D. Balicer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (23 papers), Vaccine Coverage and Hesitancy (21 papers) and Disaster Response and Management (17 papers). Ran D. Balicer collaborates with scholars based in Israel, United States and United Kingdom. Ran D. Balicer's co-authors include Noa Dagan, Marc Lipsitch, Noam Barda, Ben Y. Reis, Miguel A. Hernán, Eldad Kepten, Oren Miron, Mark A. Katz, Isaac S. Kohane and Daniel J. Barnett and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Ran D. Balicer

255 papers receiving 8.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

2021 1.6k citations Noa Dagan, Noam Barda et al. New England Journal of Medicine profile →
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

2021 672 citations Noam Barda, Noa Dagan et al. New England Journal of Medicine profile →
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

2021 558 citations Noam Barda, Noa Dagan et al. profile →
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge

2022 197 citations Noa Dagan, Ran D. Balicer et al. New England Journal of Medicine profile →
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy

2021 196 citations Noa Dagan, Noam Barda et al. Nature Medicine profile →
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

2021 194 citations Marc Lipsitch, Florian Krammer et al. Nature reviews. Immunology profile →

Peers

Countries citing papers authored by Ran D. Balicer

Since Specialization

Citations

This map shows the geographic impact of Ran D. Balicer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran D. Balicer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran D. Balicer more than expected).

Fields of papers citing papers by Ran D. Balicer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran D. Balicer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran D. Balicer. The network helps show where Ran D. Balicer may publish in the future.

Co-authorship network of co-authors of Ran D. Balicer

This figure shows the co-authorship network connecting the top 25 collaborators of Ran D. Balicer. A scholar is included among the top collaborators of Ran D. Balicer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran D. Balicer. Ran D. Balicer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel	International Journal of Infectious Diseases	Ashley Fowlkes, Alon Peretz et al.	1
2	Trends of common laboratory biomarkers after SARS-CoV-2 infection	Journal of Infection	Bracha Shapira, Ran D. Balicer et al.	0
3	Myocarditis following COVID ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases	European Journal of Heart Failure	Bettina Heidecker, Noa Dagan et al.	84
4	Association of opioid use disorder with healthcare utilization and cost in a public health system	Addiction	Oren Miron, Noam Barda et al.	15
5	Indirect protection of children from SARS-CoV-2 infection through parental vaccination	Science	Samah Hayek, Yatir Ben‐Shlomo et al.	34
6	BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age	New England Journal of Medicine	Chandra J. Cohen-Stavi, Noam Barda et al.	53
7	Guideline deviation and its association with specific chronic diseases among patients with multimorbidity: a cross-sectional cohort study in a care management setting	BMJ Open	Chandra J. Cohen-Stavi, Shmuel Giveon et al.	3
8	Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting	Blood	Moshe Mittelman, Noam Barda et al.	43
9	Previously undiagnosed cancer in patients with arterial thrombotic events – A population‐based cohort study	Journal of Thrombosis and Haemostasis	Avi Leader, Noa Dagan et al.	7
10	BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting breakdown →	New England Journal of Medicine	Noa Dagan, Noam Barda et al.	1619
11	SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact breakdown →	Nature reviews. Immunology	Marc Lipsitch, Florian Krammer et al.	194
12	Addressing bias in prediction models by improving subpopulation calibration	Journal of the American Medical Informatics Association	Noam Barda, Gal Yona et al.	40
13	Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization	Nature Medicine	Noa Dagan, Eldad Elnekave et al.	74
14	<p>Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study</p>	Clinical Epidemiology	Orna Reges, Moshe Hoshen et al.	15
15	Rising opioid prescription fulfillment among non-cancer and non-elderly patients—Israel’s alarming example	Regional Anesthesia & Pain Medicine	Oren Miron, Dan Zeltzer et al.	17
16	Developing a COVID-19 mortality risk prediction model when individual-level data are not available	Nature Communications	Noam Barda, Dan Riesel et al.	77
17	Mixed Methods Evaluation of Reasons Why Care Deviates From Clinical Guidelines Among Patients With Multimorbidity	Medical Care Research and Review	Chandra J. Cohen-Stavi, Calanit Key et al.	6
18	EMR-based medication adherence metric markedly enhances identification of nonadherent patients.	PubMed	Shepherd Roee Singer, Moshe Hoshen et al.	23
19	[The effect of the introduction of pneumococcal vaccination for adults as a quality measure on vaccination rates in Clalit Health Services].	PubMed	Arnon D. Cohen, Jacob Dreiher et al.	2
20	[The quality indigators program in Clalit Health Services: the first decade].	PubMed	Arnon D. Cohen, Jacob Dreiher et al.	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact